• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Biomarin Pharmaceutical

Biomarin Pharmaceutical

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. S&P 500's slow-motion breakout attempt remains in play

    S&P 500's slow-motion breakout attempt remains in play

  2. UPDATE: S&P 500's slow-motion breakout attempt remains in play

    UPDATE: S&P 500's slow-motion breakout attempt remains in play

  3. BioMarin jumps after analyst suggests merger may be in its future

    BioMarin jumps after analyst suggests merger may be in its future

  4. UPDATE: BioMarin jumps after analyst suggests merger may be in its future

    UPDATE: BioMarin jumps after analyst suggests merger may be in its future

  5. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

  6. A Young Power Couple's Kickstart Portfolio

    With "massive" student debt loads receding in the rearview mirror, a young professional couple fires up their investment plan.

  7. Our Outlook for Health-Care Stocks

    Health-care stocks are on a tear as demand slowly returns.

  8. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  9. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

  10. Our Outlook for Health-Care Stocks

    With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.